INSIGHTS ON SOLID DOSE MANUFACTURING
-
Optimizing Tablets For Even Splitting: The Pressure Sensitive Bisect Design
The pressure-sensitive bisect design allows accurate tablet splitting by maximizing facet width, optimizing angles, and balancing radius values for durability and user-friendly administration.
-
The Importance Of Polymorph Screenings
Discover how systematic polymorph screening reduces development risk, safeguards product performance, and enables confident solid‑form selection across the drug development lifecycle.
-
HPAPIS Production: "Where Micrograms Matters"
In HPAPI manufacturing, micrograms make a difference. Risk‑based containment, smart facility design, and exposure limits safeguard people, product, and performance.
-
Head Pressure In Your Hopper: What Is It, And How Do You Mitigate It?
What is head pressure in your hopper and how does it relate to tablet press performance?
-
Integration From Formulation Development To Manufacturing, Packaging2/27/2025
Adare Pharma Solutions' Pessano, Italy facility offers 220,000 sq. ft. of end-to-end services, including R&D, formulation development, clinical and commercial manufacturing, packaging, and advanced analytical capabilities.
-
Navigating High-Potency OSD Manufacturing4/13/2026
Learn how containment strategy, process design, and early risk‑based decisions influence operator protection, compliance, and long‑term manufacturing success as potency levels continue to rise.
-
GLP-1 Oral Solid Dosage Workflow - Spray Drying And Tableting6/29/2026
Optimize containment in oral GLP-1 solid dose manufacturing. Learn how closed single-use containment and flexible isolators secure blending, spray drying, and tableting workflows.
-
Benefits Of Single-Use Isolators For Cytotoxic Payload Handling6/15/2026
Managing cytotoxic ADC payloads in shared containment facilities creates mounting compliance, safety, and operational costs that single-use isolator technology is designed to address.
-
Benefits Of Isolator Technology In Fill-Finish12/10/2025
Isolator technology enhances sterility assurance, reduces contamination risk, improves operator safety, and supports regulatory compliance, making it essential for modern aseptic fill-finish operations.
SOLID DOSE MANUFACTURING SOLUTIONS
-
GMP drug product manufacturing supports solid dose and sterile parenteral development with formulation expertise, isolator fill‑finish, DEA‑licensed work, packaging, labeling, and supply‑chain services.
-
Building on the capabilities of the NP-RD10A benchtop tablet press (discussed in our previous article on USP <1062>), our services are further enhanced by the integration of the Presster™ compaction emulator. This state-of-the-art tool is designed to replicate the compaction dynamics of production tablet presses in a laboratory setting. It allows for tangible fine-tuning of the compression cycle, providing an accurate depiction of how a tablting formulation will behave under commercial manufacturing conditions. Using the Presster, Natoli Scientific can simulate full-scale production, permitting us to forecast problems before they escalate to costly production delays. Our experts can optimize the tablet design for our clients, ensuring a smooth transition from laboratory to production while adhering to the rigorous standards set by the industry including the current USP <1062> chapter.
-
Oral solid dose manufacturing supports complex formulations with flexible scales, specialized technologies, and integrated packaging for reliable clinical and commercial supply.
-
Explore aseptic filling line solutions that offer an easy-to-operate system designed to enhance production efficiency and reduce changeover time.
-
Unused Stokes 560 tablet press tooling, tooling size: 3650 x 7850 inch Caplet, 44 Lower Punch/44 Upper Punch/44 Die, manufactured by Natoli.